EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

CDSCO Approves Enhertu for Expanded Breast Cancer Use in India - India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has granted AstraZeneca permission to market its HER2-targeting cancer therapy Enhertu (trastuzumab deruxtecan) for a new, expanded breast cancer indication, as reported by Business Standard, NDTV Profit and Medical Dialogues in early August 2026. The approval extends the drug’s reach in India beyond the first-line […]
India Pharma to Miss 2030 Sales Target on Tariffs, Shipping Woes - India’s pharmaceutical sector is widely expected to miss its 2030 sales target, as a combination of US import tariffs on generic drugs and prolonged shipping disruptions weigh on export momentum. The warning was flagged by a leading pharma trade body and reported by Reuters on 4 August 2026, then echoed across multiple international outlets. For […]
CDSCO to Launch Digital Drug Regulatory Platform in 18 Months - India’s central drug regulator is betting on digital technology to speed up drug approvals and sharpen oversight. The Central Drugs Standard Control Organisation (CDSCO) has announced plans to launch the first phase of an end-to-end digital drug regulatory platform within the next 18 months — a move that could modernise how medicines are approved, licensed, […]
Dr. Reddy’s Wins US FDA Approval for Rituximab Biosimilar - Indian drugmakers are pushing deeper into the United States biologics market. Dr. Reddy’s is reported by multiple financial media outlets in early August 2026 to have secured approval from the U.S. Food and Drug Administration (FDA) for its rituximab biosimilar, with Germany’s Fresenius Kabi lined up to commercialise the product. The development underscores two converging […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us